VRDN logo

Viridian Therapeutics (VRDN) Interest Coverage Ratio

Annual Interest Coverage Ratio

-127.71
+138.52+52.03%

December 31, 2023


Summary


Performance

VRDN Interest Coverage Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRDNfinancial healthmetrics:

Quarterly Interest Coverage Ratio

-75.38
+32.49+30.12%

September 30, 2024


Summary


Performance

VRDN Quarterly Interest Coverage Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRDNfinancial healthmetrics:

Interest Coverage Ratio Formula

Interest Coverage Ratio =  
EBIT
Interest Expense

VRDN Interest Coverage Ratio Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+52.0%0.0%
3 y3 years+41.1%0.0%
5 y5 years-250.3%0.0%

VRDN Interest Coverage Ratio Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+99.5%-4.7%+99.2%
5 y5-year-159.8%+99.5%-34.5%+99.2%
alltimeall time<-9999.0%+99.5%<-9999.0%+99.2%

Viridian Therapeutics Interest Coverage Ratio History

DateAnnualQuarterly
Sep 2024
-
-75.38(-30.1%)
Jun 2024
-
-107.87(+32.0%)
Mar 2024
-
-81.70(+13.5%)
Dec 2023
-127.71(-52.0%)
-71.99(-8.2%)
Sep 2023
-
-78.43(-76.3%)
Jun 2023
-
-330.70(-19.7%)
Mar 2023
-
-412.04(+51.7%)
Dec 2022
-266.23(-99.0%)
-271.53(+54.9%)
Sep 2022
-
-175.25(-8.0%)
Jun 2022
-
-190.50(-98.0%)
Dec 2021
-26.47 K(>+9900.0%)
-9647.67(+1817.6%)
Dec 2020
-216.94(+341.4%)
-503.12(+766.3%)
Sep 2020
-
-58.08(-13.9%)
Jun 2020
-
-67.46(+20.4%)
Mar 2020
-
-56.05(-4.2%)
Dec 2019
-49.15(+34.8%)
-58.52(+8.3%)
Sep 2019
-
-54.05(+42.8%)
Jun 2019
-
-37.85(-23.0%)
Mar 2019
-
-49.13(+11.0%)
Dec 2018
-36.46
-44.25(+11.8%)
Sep 2018
-
-39.59(-0.3%)
Jun 2018
-
-39.72(+86.5%)
DateAnnualQuarterly
Mar 2018
-
-21.30(-34.7%)
Dec 2017
-68.22(-48.5%)
-32.61(-67.3%)
Sep 2017
-
-99.59(-12.1%)
Jun 2017
-
-113.25(+16.4%)
Mar 2017
-
-97.31(-54.4%)
Dec 2016
-132.41(+66.9%)
-213.23(+170.0%)
Sep 2016
-
-78.96(-26.9%)
Jun 2016
-
-108.00(-9.2%)
Mar 2016
-
-118.91(-7.5%)
Dec 2015
-79.34(+1082.4%)
-128.57(-1.4%)
Sep 2015
-
-130.33(+276.9%)
Jun 2015
-
-34.58(-70.9%)
Mar 2015
-
-118.73(-89.5%)
Dec 2014
-6.71(+6610.0%)
-1128.00(+176.3%)
Sep 2014
-
-408.25(+6843.0%)
Jun 2014
-
-5.88(+1796.8%)
Mar 2014
-
-0.31(-155.4%)
Dec 2013
-0.10(-96.0%)
0.56(-201.8%)
Sep 2013
-
-0.55(+323.1%)
Jun 2013
-
-0.13(-23.5%)
Mar 2013
-
-0.17
Dec 2012
-2.53
-

FAQ

  • What is Viridian Therapeutics annual interest coverage ratio?
  • What is the all time high annual interest coverage ratio for Viridian Therapeutics?
  • What is Viridian Therapeutics annual interest coverage ratio year-on-year change?
  • What is Viridian Therapeutics quarterly interest coverage ratio?
  • What is the all time high quarterly interest coverage ratio for Viridian Therapeutics?
  • What is Viridian Therapeutics quarterly interest coverage ratio year-on-year change?

What is Viridian Therapeutics annual interest coverage ratio?

The current annual interest coverage ratio of VRDN is -127.71

What is the all time high annual interest coverage ratio for Viridian Therapeutics?

Viridian Therapeutics all-time high annual interest coverage ratio is -0.10

What is Viridian Therapeutics annual interest coverage ratio year-on-year change?

Over the past year, VRDN annual interest coverage ratio has changed by +138.52 (+52.03%)

What is Viridian Therapeutics quarterly interest coverage ratio?

The current quarterly interest coverage ratio of VRDN is -75.38

What is the all time high quarterly interest coverage ratio for Viridian Therapeutics?

Viridian Therapeutics all-time high quarterly interest coverage ratio is 0.56

What is Viridian Therapeutics quarterly interest coverage ratio year-on-year change?

Over the past year, VRDN quarterly interest coverage ratio has changed by 0.00 (0.00%)